Client Success

We leverage our unparalleled relationships across the life sciences ecosystem to connect the right leaders with the right companies. 


Recent Client Success

Filter by placement

CBO|November 30, 2022

Chief Corporate Development Officer

Client Team Lead: Matt Toner
Client: Juvena Therapeutics, Inc.
Juvena Therapeutics, Inc. (“Juvena”), a biotechnology company scaling a computational platform to map the therapeutic potential of secreted proteins, announced today the hiring of four senior leaders with significant industry experience in both small and large…
CMO|November 8, 2022

Executive Vice President, Chief Medical Officer

Client Team Lead: Sarah McKenna
Client: Akari Therapeutics, Plc
Akari Therapeutics, Plc (Nasdaq: AKTX), a late-stage biotechnology company developing advanced therapies for autoimmune and inflammatory diseases, today announced the appointment of John F. Neylan, III, MD, as Executive Vice President, Chief Medical Officer, effective today.
CEO|September 28, 2022

President, Chief Executive Officer

Client Team Lead: Matt Toner
Client: Reunion Neuroscience Inc.
Reunion Neuroscience Inc. (TSX: REUN, NASDAQ: REUN) ("Reunion" or the “Company”), a leader in novel psychedelic drug development committed to innovating therapeutic solutions for mental health conditions by developing proprietary serotonin receptor agonist compounds, announced the appointment…
VP|September 20, 2022

Vice President, Real World Evidence & Outcomes

Client Team Lead: John Spencer
Client: Guardant Health
Guardant Health is a leading precision oncology company focused on helping conquer cancer globally through its proprietary blood tests, vast data sets, and advanced analytics.
Guardant sought to change the global landscape from diagnosing cancer to screening…
CEO|September 7, 2022

Chief Executive Officer

Client Team Lead: John Spencer
Client: Sengenics LLC.
Sengenics LLC, driving the discovery of next-gen biomarkers, announces that Jerry Williamson has been appointed the company’s Chief Executive Officer, effective immediately. With more than 30 years of experience in bioscience markets for life science research, diagnostics…
Director|July 11, 2022

Medical Director – CNS

Client Team Lead: Andy Cronin
Client: Alkahest
Alkahest, a subsidiary of Grifols, is a biotechnology company focused on developing therapies derived from blood to treat various neurological diseases.
For their Medical Director – CNS, Alkahest needed a neurologist to drive the clinical strategy for their…
CFO|June 27, 2022

Chief Financial Officer

Client Team Lead: Matt Toner
Client: Aptose Biosciences, Inc.
Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO, TSX: APS), a clinical-stage precision oncology company developing highly differentiated oral kinase inhibitors to treat hematologic malignancies, today announced the appointment of Mr. Fletcher Payne to the…
BOD|June 24, 2022

Board of Directors

Client Team Lead: Caroline Hunt
Client: Pixium Vision SA
Pixium Vision SA (Euronext Growth Paris - FR0011950641; Mnemo: ALPIX), a bioelectronics company that develops innovative bionic vision systems to enable patients who have lost their sight to live more independent lives, announces today the appointment…

Learn More About Our Search Opportunities

Need help finding the right opportunity? We'll be happy to help!